Oppenheimer Cuts HCA Healthcare (NYSE:HCA) Price Target to $485.00

HCA Healthcare (NYSE:HCA) had its price target lowered by Oppenheimer from $520.00 to $485.00 in a report issued on Monday, MarketBeat Ratings reports. The firm currently has an outperform rating on the stock.

A number of other brokerages have also recently issued reports on HCA. Argus decreased their target price on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research report on Monday, May 4th. Weiss Ratings downgraded shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Wells Fargo & Company set a $369.00 price target on shares of HCA Healthcare in a report on Monday, July 20th. Finally, KeyCorp cut their price objective on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a research report on Monday. Fourteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $465.05.

HCA Healthcare Trading Down 2.3%

Shares of NYSE:HCA opened at $408.39 on Monday. HCA Healthcare has a 1 year low of $342.71 and a 1 year high of $556.52. The firm has a fifty day moving average price of $386.80 and a 200 day moving average price of $452.03. The stock has a market capitalization of $90.60 billion, a PE ratio of 13.67, a P/E/G ratio of 1.46 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same quarter in the previous year, the firm earned $6.84 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, sell-side analysts forecast that HCA Healthcare will post 29.38 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.

Hedge Funds Weigh In On HCA Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of HCA. Sumitomo Life Insurance Co. boosted its stake in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after buying an additional 20 shares in the last quarter. MJP Associates Inc. ADV lifted its holdings in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after acquiring an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC grew its holdings in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after purchasing an additional 21 shares during the last quarter. Anchyra Partners LLC lifted its holdings in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd grew its stake in HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock worth $1,833,000 after buying an additional 22 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare News Roundup

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
• Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
• Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
• Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
• Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
• Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.